Thus, our findings suggest that HSF1 may be an independent predictor of survival and prognosis in patients with pancreatic cancer and may serve as a target for the diagnosis and treatment of pancreatic cancer. The gene discussed is HSF1; the disease is familial pancreatic carcinoma.